Immediate Impact
3 by Nobel laureates 5 from Science/Nature 75 standout
Citing Papers
Medications for Obesity
2024 Standout
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Standout
Works of C.E. Rasmussen being referenced
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| C.E. Rasmussen | 187 | 179 | 160 | 228 | 192 | 20 | 652 | |
| D. F. Larson | 116 | 290 | 95 | 164 | 130 | 17 | 728 | |
| A. Pacifico | 43 | 67 | 198 | 245 | 193 | 29 | 818 | |
| T. Gibson | 151 | 230 | 88 | 142 | 54 | 26 | 788 | |
| A. G. Kasselberg | 41 | 101 | 279 | 159 | 126 | 23 | 815 | |
| F Schmid | 39 | 143 | 366 | 105 | 126 | 27 | 725 | |
| Della Cole | 32 | 204 | 91 | 177 | 102 | 16 | 632 | |
| Stephanie R. Beck | 81 | 203 | 105 | 140 | 93 | 17 | 772 | |
| F. Oberhäuser | 34 | 72 | 278 | 99 | 71 | 19 | 772 | |
| Wan‐Jing Ho | 99 | 267 | 83 | 121 | 67 | 46 | 661 | |
| C. Vandepol | 42 | 312 | 53 | 132 | 129 | 19 | 758 |
All Works
Login with ORCID to disown or claim papers
Loading papers...